Cargando…

Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer

BACKGROUND: The selective pressure imposed by chemotherapy creates a barrier to tumor eradication and an opportunity for metastasis and recurrence. As a newly discovered stemness marker of pancreatic ductal adenocarcinoma (PDAC), the impact of CD9 on tumor progression and patient's prognosis re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xuan, Zhang, Wu‐Hu, Gao, He‐Li, Li, Tian‐Jiao, Xu, Hua‐Xiang, Li, Hao, Li, Peng‐Cheng, Wang, Xu, Yu, Xian‐Jun, Wang, Wen‐Quan, Liu, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279986/ https://www.ncbi.nlm.nih.gov/pubmed/35622458 http://dx.doi.org/10.1002/jcla.24517

Ejemplares similares

Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities
por: Lin, L Y, et al.
Publicado: (2016)

Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties
por: Wang, Shihua, et al.
Publicado: (2018)

Endowments
Publicado: (1894)

Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma
por: Li, Zhendong, et al.
Publicado: (2022)

The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma
por: Kawahara, Kenji, et al.
Publicado: (2022)

Endowed Research
Publicado: (1909)

The Endowment of Research
Publicado: (1902)

The Endowment of Research
Publicado: (1903)

The Art of Endowment
Publicado: (1918)

The Endowment of Research
Publicado: (1898)

The Endowment of Motherhood
Publicado: (1919)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

Prognostic Value of Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Carcinoma Followed by Pancreatectomy with Portal Vein Resection and Reconstruction with Venous Allograft
por: Huang, Jin-Can, et al.
Publicado: (2022)

The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
por: Lu, Yanan, et al.
Publicado: (2019)

The Evaluation Value of CT in the Efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients
por: Mou, Daying, et al.
Publicado: (2022)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors
por: Zhang, Wu-Hu, et al.
Publicado: (2020)

Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
por: Wang, Hongxia, et al.
Publicado: (2021)

Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer
por: Li, Fengling, et al.
Publicado: (2022)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
por: Wang, Ruo-Xi, et al.
Publicado: (2018)

Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
por: Chen, Min-Bin, et al.
Publicado: (2012)

Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients
por: Ke, Zi-Rui, et al.
Publicado: (2022)

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
por: Xu, Yaqian, et al.
Publicado: (2020)

Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
por: Lin, Guang-Tan, et al.
Publicado: (2022)

A high interferon gamma signature of CD8(+) T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer
por: Li, Sen, et al.
Publicado: (2023)

Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult
por: Boeck, S, et al.
Publicado: (2014)

Preschoolers and the Endowment Effect
por: Da Silva, Sergio, et al.
Publicado: (2014)

The Need for Endowed Research
Publicado: (1905)

The Endowment of Pathological Research
Publicado: (1908)

The State Endowment of Motherhood
Publicado: (1916)

The Advertisements of Endowed Hospitals
Publicado: (1887)

The Differences of Natural Endowment
Publicado: (1833)

University of Buffalo Endowments
Publicado: (1904)

Precisely Endowing Colloidal Particles with Silica Branches
por: Zhao, Bin, et al.
Publicado: (2019)

Natural variation of codon repeats in COLD11 endows rice with chilling resilience
por: Li, Zhitao, et al.
Publicado: (2023)

CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
por: Lin, Yun, et al.
Publicado: (2021)

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA‐negative breast cancers
por: Xu, Ye, et al.
Publicado: (2017)

Prognostic value of NF-κB, CD9, and VEGF in gastrointestinal stromal tumors
por: Tasdemir, Arzu, et al.
Publicado: (2013)

Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy
por: Xia, Xibin, et al.
Publicado: (2022)

Endowing improved osteogenic activities with collagen membrane by incorporating biocompatible iron oxide nanoparticles
por: Li, Zheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d5i8euqt6l6mrtq4u2vprpkhvf